145 related articles for article (PubMed ID: 38753459)
1. Electrophoretic Microfluidic Characterization of mRNA- and pDNA-Loaded Lipid Nanoparticles.
De Peña AC; Zimmer D; Gutterman-Johns E; Chen NM; Tripathi A; Bailey-Hytholt CM
ACS Appl Mater Interfaces; 2024 May; 16(21):26984-26997. PubMed ID: 38753459
[TBL] [Abstract][Full Text] [Related]
2. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology.
Ottonelli I; Adani E; Bighinati A; Cuoghi S; Tosi G; Vandelli MA; Ruozi B; Marigo V; Duskey JT
Int J Nanomedicine; 2024; 19():4235-4251. PubMed ID: 38766661
[TBL] [Abstract][Full Text] [Related]
4. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.
Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139
[TBL] [Abstract][Full Text] [Related]
5. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
6. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
[TBL] [Abstract][Full Text] [Related]
7. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
[TBL] [Abstract][Full Text] [Related]
8. Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection.
Maeki M; Uno S; Sugiura K; Sato Y; Fujioka Y; Ishida A; Ohba Y; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2024 Jan; 16(2):2110-2119. PubMed ID: 38141015
[TBL] [Abstract][Full Text] [Related]
9. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
11. The mechanical properties of lipid nanoparticles depend on the type of biomacromolecule they are loaded with.
de Chateauneuf-Randon S; Bresson B; Ripoll M; Huille S; Barthel E; Monteux C
Nanoscale; 2024 Jun; 16(22):10706-10714. PubMed ID: 38700424
[TBL] [Abstract][Full Text] [Related]
12. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
13. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.
Cui L; Pereira S; Sonzini S; van Pelt S; Romanelli SM; Liang L; Ulkoski D; Krishnamurthy VR; Brannigan E; Brankin C; Desai AS
Nanoscale; 2022 Jan; 14(4):1480-1491. PubMed ID: 35024714
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection.
Thomas A; M Garg S; De Souza RAG; Ouellet E; Tharmarajah G; Reichert D; Ordobadi M; Ip S; Ramsay EC
Methods Mol Biol; 2018; 1792():193-203. PubMed ID: 29797261
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery.
Qin Y; Walters AA; Rouatbi N; Wang JT; Abdel-Bar HM; Al-Jamal KT
Biomaterials; 2023 Aug; 299():122158. PubMed ID: 37243988
[TBL] [Abstract][Full Text] [Related]
16. Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes.
Scalzo S; Santos AK; Ferreira HAS; Costa PA; Prazeres PHDM; da Silva NJA; Guimarães LC; E Silva MM; Rodrigues Alves MTR; Viana CTR; Jesus ICG; Rodrigues AP; Birbrair A; Lobo AO; Frezard F; Mitchell MJ; Guatimosim S; Guimaraes PPG
Int J Nanomedicine; 2022; 17():2865-2881. PubMed ID: 35795081
[TBL] [Abstract][Full Text] [Related]
17. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
Francia V; Schiffelers RM; Cullis PR; Witzigmann D
Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
[TBL] [Abstract][Full Text] [Related]
18.
Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
[TBL] [Abstract][Full Text] [Related]
19. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles.
Ross-Thriepland D; Bornot A; Butler L; Desai A; Jaiswal H; Peel S; Hunter MR; Odunze U; Isherwood B; Gianni D
SLAS Discov; 2020 Jul; 25(6):605-617. PubMed ID: 32441189
[TBL] [Abstract][Full Text] [Related]
20. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
